These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 5307100)

  • 61. [Effect of surface-active compounds on the healing of local radiation injuries to the skin].
    Baraboĭ VA; Pis'ko GT; Pratsiuk LI; Protsyk VS
    Med Radiol (Mosk); 1977 Jul; 22(7):58-63. PubMed ID: 333219
    [No Abstract]   [Full Text] [Related]  

  • 62. Interpretation of human urinary excretion of plutonium for cases treated with DTPA.
    Jech JJ; Andersen BV; Heid KR
    Health Phys; 1972 Jun; 22(6):787-92. PubMed ID: 5084012
    [No Abstract]   [Full Text] [Related]  

  • 63. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
    Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
    Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
    [No Abstract]   [Full Text] [Related]  

  • 64. DTPA therapy of 241Am from a simulated wound site.
    Lloyd RD; Taylor GN; Maya CW; McFarland SS; Atherton DR
    Health Phys; 1975 Nov; 29(5):808-11. PubMed ID: 1193906
    [No Abstract]   [Full Text] [Related]  

  • 65. DTPA treatment schedules for decorporation of 239Pu from simulated wounds.
    Gemenetzis E; Volf V
    Health Phys; 1977 Jun; 32(6):489-92. PubMed ID: 881349
    [No Abstract]   [Full Text] [Related]  

  • 66. Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.
    Breustedt B; Blanchardon E; Berard P; Fritsch P; Giussani A; Lopez MA; Luciani A; Nosske D; Piechowski J; Schimmelpfeng J; Sérandour AL
    Radiat Prot Dosimetry; 2009 Feb; 134(1):38-48. PubMed ID: 19351653
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
    Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
    Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Decorporation from beagles of a mixture of monomeric and particulate plutonium using Ca-DTPA and Zn-DTPA: dependence upon frequency of administration.
    Lloyd RD; Boseman JJ; Taylor GN; Bruenger FW; Atherton DR; Stevens W; Mays CW
    Health Phys; 1978 Aug; 35(2):217-27. PubMed ID: 701018
    [No Abstract]   [Full Text] [Related]  

  • 69. [Plutonium-239 metabolism in chemical skin burns].
    Il'in LA; Beliaev IK
    Radiobiologiia; 1983; 23(6):778-82. PubMed ID: 6657939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The metabolism and decorporation of Pu after inhalation of the tributyl phosphate complex by the rat.
    Stradling GN; Stather JW; Sumner SA; Moody JC; Hodgson A
    Health Phys; 1985 Sep; 49(3):499-502. PubMed ID: 4030339
    [No Abstract]   [Full Text] [Related]  

  • 71. Assessment and management of a plutonium contaminated wound case.
    Schofield GB; Howells H; Ward F; Lynn JC; Dolphin GW
    Health Phys; 1974 Jun; 26(6):541-54. PubMed ID: 4836700
    [No Abstract]   [Full Text] [Related]  

  • 72. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The behavior of 237 Np in the rat.
    Morin M; Nenot JC; Lafuma J
    Health Phys; 1973 Mar; 24(3):311-5. PubMed ID: 4691639
    [No Abstract]   [Full Text] [Related]  

  • 74. Computer simulation of metal ion equilibria in biofluids. IV. Plutonium speciation in human blood plasma and chelation therapy using polyaminopolycarboxylic acids.
    Duffield JR; May PM; Williams DR
    J Inorg Biochem; 1984 Mar; 20(3):199-214. PubMed ID: 6425458
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Experimental contribution on the question of lead decorporation by chelating agents].
    Catsch A
    Arzneimittelforschung; 1967 Apr; 17(4):493-5. PubMed ID: 5632447
    [No Abstract]   [Full Text] [Related]  

  • 76. DTPA therapy for chelation of 239 Pu in bone: the influence of bone remodelling.
    James AC; Taylor DM
    Health Phys; 1971 Jul; 21(1):31-9. PubMed ID: 5114657
    [No Abstract]   [Full Text] [Related]  

  • 77. [Experimental model on DTPA therapy of radioactivity contaminated wounds].
    Bömer H
    Strahlentherapie; 1972 Jun; 143(6):664-9. PubMed ID: 5071563
    [No Abstract]   [Full Text] [Related]  

  • 78. The effects of desferrioxamine on the retention of actinide elements in the rat.
    Taylor DM
    Health Phys; 1967 Feb; 13(2):135-40. PubMed ID: 6029424
    [No Abstract]   [Full Text] [Related]  

  • 79. [Research in the complexon series. I. Detoxicant capacity of Ca-DTPA in experimental chronic plutonium poisoning in rats. II. Influence of the repeated intravenous administration of Ca-DTPA on the elimination of trace elements in rats. 3. Preliminary results of the study, in rats, of the modalities of calcium elimination after Ca45-DTPA injection].
    Truhaut R; Boudène C; Lutz M
    Ann Biol Clin (Paris); 1966; 24(3):419-39. PubMed ID: 5932716
    [No Abstract]   [Full Text] [Related]  

  • 80. A mathematical model for estimation of plutonium in the human body from urine data influenced by DTPA therapy.
    Hall RM; Poda GA; Fleming RR; Smith JA
    Health Phys; 1978 May; 34(5):419-31. PubMed ID: 711453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.